» Articles » PMID: 35980277

Distinguishing Cushing's Disease from the Ectopic ACTH Syndrome: Needles in a Haystack or Hiding in Plain Sight?

Overview
Specialty Endocrinology
Date 2022 Aug 18
PMID 35980277
Authors
Affiliations
Soon will be listed here.
Abstract

In the context of ACTH-dependent Cushing's syndrome, ectopic ACTH secretion from a neuroendocrine tumour is not uncommon, and needs to be carefully differentiated from pituitary-dependent Cushing's syndrome, Cushing's disease, in order to optimise therapy. Some cases may be quite obvious, while in others the diagnosis may be difficult to confirm and the source of ACTH problematic, as many clinical and biochemical tests may overlap with Cushing's disease. Imaging is essential, but needs to be interpreted in the light of both anatomical as well as functional imaging modalities. In this review we summarise some of the main diagnostic problems, and emphasise the multimodal and interdisciplinary nature of the diagnostic pathways.

Citing Articles

Cushing syndrome.

Nieman L, Castinetti F, Newell-Price J, Valassi E, Drouin J, Takahashi Y Nat Rev Dis Primers. 2025; 11(1):4.

PMID: 39848955 DOI: 10.1038/s41572-024-00588-w.


Unusual Presentation of Case of a Lung Carcinoid Tumor With Ectopic Adrenocorticotropic Secretion (EAS) Associated With Acute Weight Gain and Peripheral Edema.

Abouibrahim M, Rahman M, Zafar M, Berliti S, Hacikurt K, Dashora U Cureus. 2024; 16(7):e63619.

PMID: 39092370 PMC: 11290955. DOI: 10.7759/cureus.63619.


The relationship between temporal muscle thickness and disease activity in Cushing's disease.

Ozaydin D, Demir A, Oz A, Birol A, Sulu C, Sahin S J Endocrinol Invest. 2023; 46(11):2411-2420.

PMID: 37704872 DOI: 10.1007/s40618-023-02195-0.


Catastrophic ACTH-secreting pheochromocytoma: an uncommon and challenging entity with multifaceted presentation.

Foppiani L, Poeta M, Rutigliani M, Parodi S, Catrambone U, Cavalleri L Endocrinol Diabetes Metab Case Rep. 2023; 2023(2).

PMID: 37162230 PMC: 10266445. DOI: 10.1530/EDM-22-0308.


Distinguishing Cushing's disease from the ectopic ACTH syndrome: Needles in a haystack or hiding in plain sight?.

Hayes A, Grossman A J Neuroendocrinol. 2022; 34(8):e13137.

PMID: 35980277 PMC: 9542389. DOI: 10.1111/jne.13137.


References
1.
Hermus A, Pieters G, Pesman G, Smals A, BENRAAD T, KLOPPENBORG P . The corticotropin-releasing-hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome. Lancet. 1986; 2(8506):540-4. DOI: 10.1016/s0140-6736(86)90113-3. View

2.
Wengander S, Trimpou P, Papakokkinou E, Ragnarsson O . The incidence of endogenous Cushing's syndrome in the modern era. Clin Endocrinol (Oxf). 2019; 91(2):263-270. DOI: 10.1111/cen.14014. View

3.
de Bruin C, Hofland L, Nieman L, Van Koetsveld P, Waaijers A, Sprij-Mooij D . Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion. J Clin Endocrinol Metab. 2011; 97(2):455-62. PMC: 3275368. DOI: 10.1210/jc.2011-1264. View

4.
Isidori A, Kaltsas G, Pozza C, Frajese V, Newell-Price J, Reznek R . The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab. 2005; 91(2):371-7. DOI: 10.1210/jc.2005-1542. View

5.
Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz N . Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021; 9(12):847-875. PMC: 8743006. DOI: 10.1016/S2213-8587(21)00235-7. View